Jean S. Frenel
Angers, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03.
Journal: Breast (Edinburgh, Scotland)
Published: August 26, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.
Journal: Nature medicine
Published: March 31, 2025
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
Journal: Scientific reports
Published: March 12, 2023
Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101.
Journal: Neuro-oncology practice
Published: July 20, 2022
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Journal: Gynecologic oncology
Published: June 21, 2022
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer.
Journal: Therapeutic advances in medical oncology
Published: July 09, 2021
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 21, 2021
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2020
Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer.
Journal: Therapeutic advances in medical oncology
Published: October 28, 2019
Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data.
Journal: Cancer management and research
Published: October 15, 2018
Emotional distress and subjective impact of the disease in young women with breast cancer and their spouses.
Journal: Future oncology (London, England)
Published: December 02, 2017
Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy.
Journal: Therapeutic advances in medical oncology
Published: March 29, 2016
Last Updated: 09/26/2026